Literature DB >> 10412861

Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study.

G R Lerner1, B A Warady, E K Sullivan, S R Alexander.   

Abstract

The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) summarizes data submitted from 130 centers on 2,208 patients in whom 2,787 independent courses of dialysis were performed between 1 January 1992 and 16 January 1996. Approximately two-thirds of the dialysis population were maintained on peritoneal dialysis (PD), with automated PD remaining the preferred modality. There were 964 episodes of peritonitis in 1,018 patient years, yielding an overall peritonitis rate of 1 episode every 13 patient months. More PD patients attended school full time than hemodialysis (HD) patients at baseline (77% vs. 45%), which continued at 6, 12, and 24 months of followup. There were fewer Hispanic patients who were full-time students, whether on HD or PD, compared with white or black patients; 18% of Hispanic patients did not attend school, even though they were medically capable. The majority of dialysis courses terminated due to transplantation (54%), with change in dialysis modality the next most-common reason (28%). Early dialysis termination for any reason was seen more often in HD than PD (40% vs. 23% at 6 months), but by 24 months similar percentages of PD and HD courses had been terminated (75% HD, 72% PD). The most-common PD access was a Tenckhoff catheter with a single cuff, a straight tunnel and lateral exit site. The majority of HD accesses were external percutaneous catheters, with the sublcavian vein the most-common site. Erythropoietin was administered in 93% of HD and PD patients at 24 months.

Entities:  

Mesh:

Year:  1999        PMID: 10412861     DOI: 10.1007/s004670050631

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

1.  Blood pressure control in pediatric hemodialysis: the Midwest Pediatric Nephrology Consortium Study.

Authors:  Rene' G VanDeVoorde; Gina M Barletta; Deepa H Chand; Ian G Dresner; Jerome Lane; Jeffrey Leiser; Jen-Jar Lin; Cynthia G Pan; Hiren Patel; Rudolph P Valentini; Mark M Mitsnefes
Journal:  Pediatr Nephrol       Date:  2006-11-07       Impact factor: 3.714

Review 2.  Fungal peritonitis in children on peritoneal dialysis.

Authors:  Renske Raaijmakers; Cornelis Schröder; Leo Monnens; Elisabeth Cornelissen; Adilla Warris
Journal:  Pediatr Nephrol       Date:  2006-11-17       Impact factor: 3.714

Review 3.  Clinical practice guidelines for pediatric peritoneal dialysis.

Authors:  Colin T White; Manjula Gowrishankar; Janusz Feber; Verna Yiu
Journal:  Pediatr Nephrol       Date:  2006-07-04       Impact factor: 3.714

4.  Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease.

Authors:  Amy C Wilson; Michael F Schneider; Christopher Cox; Larry A Greenbaum; Jeffrey Saland; Colin T White; Susan Furth; Bradley A Warady; Mark M Mitsnefes
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

5.  Prevention of peritonitis in children receiving peritoneal dialysis.

Authors:  Ari Auron; Steve Simon; Walter Andrews; Linda Jones; Shirley Johnson; Gulam Musharaf; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

6.  Small bowel herniation and gangrene from peritoneal dialysis catheter exit site.

Authors:  Kenneth K Y Wong; Lawrence C L Lan; Steve C L Lin; Paul K H Tam
Journal:  Pediatr Nephrol       Date:  2003-02-07       Impact factor: 3.714

Review 7.  Long-term outcome of chronic dialysis in children.

Authors:  Rukshana Shroff; Sarah Ledermann
Journal:  Pediatr Nephrol       Date:  2008-01-23       Impact factor: 3.714

8.  Quercetin protects human mesothelial cells against exposure to peritoneal dialysis fluid.

Authors:  Andrea Riesenhuber; David C Kasper; Regina Vargha; Michaela Endemann; Christoph Aufricht
Journal:  Pediatr Nephrol       Date:  2007-04-25       Impact factor: 3.714

Review 9.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

10.  Morbidity and mortality in children with anemia at initiation of dialysis.

Authors:  Bradley A Warady; Martin Ho
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.